drugset / Trial / NCT00289809
TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the maximum tolerated dose of the TLC D-99 combined with ifosfamide and then the efficacy of this combination in terms of overall response rate, time to progression and time of response
Timeline
- Start
- 2006-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 40 mg/m2 | — |
| Subject | Ifosfamide | Small molecule | 3000 mg/m2 | — |